Fundraising FoxOrbiMed — 2018 Investments
9 investments dated 2018 · listed companies and verified rows first · show all
Emergent BioSolutions is a public health company that develops, manufactures, and supplies medical countermeasures for national security and preparedness, along with commercialized products addressing threats such as the opioid epidemic.
Advanced ManufacturingBiotechHealthtechGaithersburg, US
Fuad El-Hibri(Director, Executive Officer)inRobert G Kramer(Executive Officer)inKatherine Strei(Executive Officer)Adam R Havey(Executive Officer)inDaniel J Abdun-Nabi(Executive Officer, Director)inJoseph C. Papa(President, CEO and Director)
Co-investorsAdvent Life Sciences
Enyo Pharma is a biotechnology company focused on drug development in the life sciences and therapeutics field.
BiotechHealthtechMedical DevicesLyon, FR
Jacky Vonderscher(Co-founder & CEO)inLaurène Meyniel-Schicklin(Founder, Head of Bioinformatics)inBenoît de Chassey(Founder, Head of Drug Discovery Platform)inPatrice André(Founder, Medical Advisor)inVincent Lotteau(Founder, Advisor)Jean-Jacques Garaud(Co-founder)in
Co-investorsAndera PartnersSofinnova PartnersBpifrance
BiotechCambridge, US
William C. Shakespeare(Director)in
BoardIain Dukes(Executive Officer, Director)inMichael Rome(Director)in
Board seatCarl Gordon· per SEC Form D
Co-investorsForesite CapitalLongitude CapitalNextech InvestNexTech VenturesOmega FundsPontifax Venture Capital+2 more
Reviral operates an affiliate review site that ranks and reviews online casinos not registered with the UK's GamStop self-exclusion scheme, comparing licences, bonuses, wagering terms, payout speeds, and payment methods.
ConsumerMedia & Entertainment
Co-investorsAndera PartnersBrace PharmaNew Leaf Venture PartnersWellcome Trust
BiotechDigital HealthMedical DevicesSeattle, US
Peter A. Thompson(Executive Officer, Director)in
Co-investorsEcoR1 CapitalPontifax Venture CapitalRA CapitalUS Venture PartnersAlexandriaNextech Invest
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BELLUS HealthPrevail TherapeuticsAttenuaSynthorx
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.